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PURPOSE. Soft tissue calcification is a pathological condition. Matrix Gla (MGP) is a potent
mineralization inhibitor secreted by cartilage chondrocytes and arteries’ vascular smooth
muscle cells. Mgp knock-out mice die at 6 weeks due to massive arterial calcification. Arterial
calcification results in arterial stiffness and higher systolic blood pressure. Intriguingly, MGP
was highly abundant in trabecular meshwork (TM). Because tissue stiffness is relevant to
glaucoma, we investigated which additional eye tissues use Mgp’s function using knock-in
mice.
METHODS. An Mgp–Cre-recombinase coding sequence (Cre) knock-in mouse, containing Mgp
DNA plus an internal ribosomal entry site (IRES)-Cre-cassette was generated by homologous
recombination. Founders were crossed with Cre-mediated reporter mouse R26R-lacZ. Their
offspring expresses lacZ where Mgp is transcribed. Eyes from MgpCre/þ;R26RlacZ/þ (Mgp-lacZ
knock-in) and controls, 1 to 8 months were assayed for b-gal enzyme histochemistry.
RESULTS. As expected, Mgp-lacZ knock-in’s TM was intensely blue. In addition, this mouse
revealed high specific expression in the sclera, particularly in the peripapillary scleral region
(ppSC). Ciliary muscle and sclera above the TM were also positive. Scleral staining was
located immediately underneath the choroid (chondrocyte layer), began midsclera and was
remarkably high in the ppSC. Cornea, iris, lens, ciliary body, and retina were negative. All mice
exhibited similar staining patterns. All controls were negative.
CONCLUSIONS. Matrix Gla’s restricted expression to glaucoma-associated tissues from anterior
and posterior segments suggests its involvement in the development of the disease. Matrix
Gla’s anticalcification/antistiffness properties in the vascular tissue, together with its high TM
and ppCS expression, place this gene as a strong candidate for TM’s softness and sclera’s
stiffness regulation in glaucoma.
Keywords: Matrix Gla, knock-in mice, reporter mice, trabecular meshwork, peripapillary
sclera, glaucoma
Glaucoma is a complex optic neuropathy that results inirreversible blindness. It is well-established that elevated
IOP is the principal risk factor associated with the development
of the disease.1 Physiological and/or elevated IOP is determined
by the resistance offered to aqueous humor flow by the
trabecular meshwork (TM). The TM is a spongiform soft tissue
formed by different types of endothelial-like cells, which use a
variety of functions to regulate IOP. One of its most relevant
functions is that which controls extracellular matrix (ECM)
composition and deposition levels, which has been shown to
have a direct correlation with increased flow resistance and
glaucoma.2 Collagen and elastic fibers are key components of
this extracellular space and contribute to the formation of the
scaffold that helps maintaining the TM’s unique architecture.3
Other tissues of the anterior segment assist the TM on its IOP
regulatory function and contribute to modulations of IOP. Thus,
the ciliary muscle, which intertwines posteriorly with the TM,
affects IOP by contracting and pulling on the trabecular beams
consequently opening spaces in the outflow pathway.4,5
Another tissue, the ciliary body, can modulate the outcome of
total IOP by increasing or decreasing secretion of aqueous
humor, which would then flow through the TM and cause
decrease or increase of IOP. The elevated IOP generated in the
anterior segment is transmitted to the back of the eye where
the sclera senses the pressure fluctuations and exerts a
biomechanical strain on the optic nerve (ON), contributing to
the death of retinal ganglion cells (RGCs).6–8 It has been
reported that the TM tissue from postmortem glaucoma
patients is stiffer than that of controls.9 Also, it has been
proposed that the degree of stiffness of the sclera might be an
important determinant of the extent of susceptibility of ON
damage in glaucoma.10,11
Identification of genes, which are involved in the function
and pathology of any of the glaucoma associated eye tissues
would not only provide further understanding of the mecha-
nisms of the disease but will open the door to new
therapeutics. Early studies from our laboratory had identified
the Matrix Gla gene (MGP) among the 10 most highly
expressed genes in the human TM.12,13 Transcription of the
gene was altered by the mechanical forces of pressure and by
other IOP-inducing agents such as TGF-b and dexametha-
sone.13,14 We had also shown that not only the gene, but the
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encoded MGP protein, was present in the TM tissue in its
active conformation and that the activity of the enzyme
responsible for its activation, c-Carboxylase, was very high in
the TM tissue.15
Matrix Gla binds calcium and is a potent inhibitor of
calcification.16 While mineralization of bone and tooth is a
physiological process, soft tissue calcification is a pathological
condition. In cartilage, calcification leads to loss of plasticity
and bone formation. In the cartilage, MGP is highly secreted by
chondrocytes and is thought to be responsible for keeping the
tissue from calcifying. In the arteries, where MGP is highly
abundant in the vascular smooth muscle cells (VSMCs) of the
tunica media, calcification leads to formation of atherosclerotic
plaques and calcified cartilaginous lesions.17,18 In patients,
MGP polymorphisms have been linked to coronary artery
calcification.19 An autosomal recessive rare disease, Keutel
syndrome, has been associated with several mutations in the
MGP gene.20–22 Patients develop abnormal soft tissue calcifi-
cation and stenosis of pulmonary arteries. Although very few
ophthalmologic exams have been described, in one case a 6-
year-old patient had sudden loss of vision in both eyes at the
age 3 and had bilateral ON atrophy.21
Matrix Gla–deficient mice die between 5 and 6 weeks of
age due to massive arterial calcification. The mechanisms by
which MGP inhibits calcification in the arteries are not totally
understood. Earlier, it had been demonstrated that after
binding to calcium, MGP binds and sequesters bone morpho-
genetic protein 2 (BMP2), a potent stimulator of osteochon-
drogenic differentiation, and thus prevents chondrogenic
transformation of the VSMCs.15,23,24 More recently, some
investigators have shown that MGP may be inhibiting
calcification by a direct effect on elastin. During calcification,
the elastic lamina (dense layer of elastic fibers of the vessel
wall) of large arteries is the first site of mineral deposition, with
elastin, a major elastic lamina protein, acting as a mineral
containing scaffold.25,26 Matrix Gla colocalizes with elastin in
the arterial elastic lamina.25,26 It is known that calcium
overload and calcification of elastic fibers lead to increase
arterial stiffness as it was determined by measuring their elastic
modulus and isobaric elasticity.27 It was also shown that such
stiffness results in higher systolic blood pressure.27
Although gene expression studies by mRNA quantification
had identified high expression of MGP in the human TM,
attempts to localize the expression of this gene in the eye had
met with little success. In situ hybridization and immunohis-
tochemistry have been unable to detect endogenous MGP in
the eye (our own unpublished results). To be able to elucidate
a temporal and spatial pattern of expression of this gene in the
eye, we made use of a set of mouse genetic tools. Engineered
mouse lines carrying the Cre-recombinase bacteriophage gene
under the control of a eukaryotic gene’s regulatory sequences
express the Cre enzyme in the eukaryotic gene’s specific cell-
type. When these mice are crossed with an engineered mouse
line containing loxP sites flanking a STOP signal for a reporter
gene, Cre recombines the two loxP sites to remove the STOP
signal, which results in expression of the reporter gene.
Histologic assessment of the reporter in the offspring of these
crosses can reveal expression of the eukaryotic gene and
accurately distinguish expression in neighboring cells. Thus,
the generation of Cre-expressing mouse lines is extremely
valuable for the determination of the desired gene expression
in cell types, its temporal distribution during embryonic and
adult development and its regulation under disease conditions.
An accurate determination of these parameters is essential to
establish a mechanistic link between MGP and glaucoma.
Therefore, to elucidate the expression pattern of Mgp in
mice, we generated knock-in mice, in which an IRES-Cre
recombinase expression cassette was inserted in between the
translational Mgp STOP signal and its polyA (pA). This knock-in
allele MgpCre was designed to express Cre recombinase only in
cells where Mgp is expressed. Here, we describe the
expression pattern of the MgpCre allele in the mouse eye.
METHODS
Mouse Strains
All animal work was performed as approved by the Institu-
tional Animal Care and Use Committee at the University of
North Carolina at Chapel Hill (UNC; Chapel Hill, NC, USA), and
conducted in accordance with the ARVO statement on the Use
of Animals in Ophthalmic Research.
The mouse strains used in the study were: C57BL/6J albino
mouse B6(Cg)-Tyr/J (B6 albino, stock # 000058; Jackson
Laboratory, Bar Harbor, ME, USA) to obtain the recipient
blastocysts, the production of chimeras and for the selection
of the germline transmission; flippase recombinase (FLP) mouse
B6.129S4-Gt(ROSA)26Sortm1(FLP1)Dym/RainJ (FLP deleter; stock
# 009086; Jackson Laboratory) for the removal of the neomycin
resistant gene (Neo) cassette; C57BL/6J (stock # 000664;
Jackson Laboratory) for removal of the FLP gene and the Crb1
rd8 mutation; loxP flanked DNA STOP preventing expression of
the lacZ gene, strain B6.129S4-Gt(ROSA)26 Sortm1Sor/J (R26R-
lacZ; stock # 003474; Jackson Laboratory), for the production of
the Mgp-Cre–mediated reporter expression.
Construction of an Mgp-Cre-Neo Knock-In
Targeting Vector
The targeting vector was constructed at the BAC Engineering
and Animal Models Core Facilities at UNC. The following steps
were conducted to produce the Mgp-IRES-Cre-FRP-flanked
PGK-Neo targeting vector: (1) An Mgp DNA fragment of 8.3 kb
was retrieved from the C57 BAC RP23-108P5 clone into a pBS-
DT plasmid (gift from C. Stewart; National Cancer Institute,
Frederick, MD, USA) by BAC recombinant technology and gap
repair28 to yield a pBS-DT-Mgp, (2) a multielement plasmid
carrying an IRES plus the Cre and flippase recognition target
site (FRT)-flanked Neo cDNAs, plasmid pBS-IRES-mnCre-FRT-
PGK-em7-Neo-FRT, was generated as follows:
 a SwaI/SalI fragment from pWP1 (Addgene the nonprofit
plasmid repository, https://www.addgene.org; in the
public domain) containing the IRES-eGFP sequence was
inserted into a pBSII-KS plasmid to produce pBS-IRES-
eGFP;
 a NcoI/SalI fragment from pmnCre (gift from P. Soriano;
Icahn School of Medicine at Mount Sinai, New York, NY,
USA) containing the mnCre cDNA, replaced eGFP in pB-
IRES-eGFP and yielded pBS-IRES-mnCre; and
 an EcoRI cassette from pGEM-FRT-PGK-em7Neo-FRT (gift
from J. Cheng; UNC) containing the FRT-flanked PGK-
Neo sequence was inserted into pBS-IRES-mnCre at the
SalI site to obtain the final multielement construct.
(3) An AscI site was created in the pBS-DT-Mgp vector
after the Mgp TAG stop signal, and (4) a Xho/Xho fragment
from the multielement plasmid containing the full IRES-Cre-
Neo cassette was inserted into the pBS-DT-Mgp plasmid at
the AscI site by blunt ligation to generate the final Mgp
targeting vector, named hereafter pMgp-Cre-Neo knock-in
(Fig. 1A). The 5 0 arm of this vector contains 1972 bp Mgp
promoter upstream sequences and the entire Mgp gene up to
the STOP codon in the fourth exon (total length 5134 bp).
The 3 0 arm contains 210 bp of 3 0UTR including the pA, plus
3022 of 3 0 genomic sequences (total length 3232 bp; Fig.
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1A). This vector (total 16,176 bp) places the Cre gene under
the control of the Mgp promoter and all Mgp internal
regulatory sequences. Confirmation of the correctness of the
inserted DNA fragments and their junctions was validated by
sequencing the inserted cassette and portions of its flanking
arms (total of 4828 bp).
Genotyping
Genotyping was performed using tail tip DNA, PCR with
primers flanking the targeting vector integration sites, and
identification of amplimers expected size by gel electrophore-
sis. Tail DNA extraction and amplification was conducted using
FIGURE 1. Diagram of the targeting strategy to generate the Mgp-Cre knock-in allele. (A) The targeting vector consists of homology arms of 1972
promoter bp, exon 1, intron 1, exon 2, intron 2, exon 3, intron 3, exon 4, and of 3022 bp of 30 genomic sequences (total 8.3 kb). Sequences
containing the IRES-Cre-FRT-flanked neomycin resistance gene cassette were inserted between the Mgp STOP signal and the 30UTR. (B, C) Targeted
locus before and after the action of the FLP recombinase. (D) Final targeted locus after removing the FLP recombinase gene. The arrowheads denote
the primer pairs used for genotyping (primer sequences in methods). (E) PCR was performed with the indicated primers pairs on genomic DNA from
the knock-in lines carrying the corresponding alleles. pA, poly-adenylation sequence; KI, knock-in. All amplimers match the expected sizes.
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a Red Extract-N-Amp Tissue PCR Kit (# XNAT; Sigma-Aldrich
Corp., St. Louis, MO, USA) following manufactures’ specifica-
tions: mix of 10 lL red extract, 1.8 lL tissue extract solution,
1.8 lL neutralization buffer, and 6 lL of 1 lM each
corresponding primers. PCR was followed at 948C 2 minutes,
(948C 45 seconds, 578C 40 seconds, 728C 1 minutes) for 38
cycles, and ending at 728C for 5 minutes before holding the
temperature at 48C.
The primers designed to identify the wild-type (WT) allele
(Mgpþ) were #1f 5 0TGTTCTGGGGGAAGAGCTCTC3 0 and #1r
50ATGTGGTTACACCTCCACAC30, which yields a 579 bp amplimer (Fig.
1A). For genotyping the Mgp-Cre-Neo knock-in allele (MgpCre-Neo),
we used two sets of primers: #2f 5 0AGGATCTCCTGTCATCTC
ACCTTGCTCCT30 and #2r 50AGTGGATCCTAGCTTGGCTGG30, expanding
Neo-Mgp 3 0arm and yielding an 889 amplimer; #3f
50CTGGAGTTTCAATACCGGAG30 and #3r 50CTCCTCTTCAGACCTGAAGT30, ex-
panding Cre-Neo and yielding a 270 amplimer (Fig. 1B). For the
Mgp-Cre-deleted Neo allele (MgpCre-delNeo, hereafter called
MgpCre allele), #4f 5 0CTGGAGTTTCAATACCGGAG3 0 and #4r
50ATGTGGTTACACCTCCACAC30, which yields 690 bp amplimer. For the
R26-FLP allele (R26FLP), we used #5f 50CACTGATATTGTAAGTAGTTTGC30
and #5r 50CTAGTGCGAAGTAGTGATCAGG30, which amplify the FLP gene
and yield a 750 bp amplimer (Fig. 1C).
For the R26R-lacZ nonrecombined allele (R26Rþ), we used
#6f 50GGAGCGGGAGAAATGGATATG30 and #6r 50AAAGTCGCTCTGAGTTGTTAT30,
which yield a 650 bp amplimer. For the R26R-lacZ recombined
allele (R26RlacZ), we used #7f 50GCGAAGAGTTTGTCCTCAACC30 and #7r




For the Crb1 WT allele (Crb1þ), #8f 50GTGAAGACAGCTACAGTT
CTGATC30 and #8r 50 GCCCCATTTGCACACTGATGA30, which yield a 220 bp
amplimer.29 For the rd8 mutation allele in the Crb1 gene
(Crb1rd8), we used #9f 50GCCCCTGTTTGCATGGAGGAAACTTGGAAGACAG
CTACAGTTCTTCTG30 and #9r 50GCCCCATTTGCACACTGATGA30, which yield a
241 bp amplimer.
Tissue Collection and Histochemical Staining for b-
galactosidase (b-gal)
Mice were euthanized by CO2 inhalation followed by cervical
dislocation immediately prior to tissue collection. Whole
globes were enucleated and incubated in fresh fixative (PBS
containing 1% paraformaldehyde [PFA], 0.2% glutaraldehyde,
0.02% NP40, and 0.01% sodium deoxycholate) at 48C for 1
hour. Eyes were then extensively washed with PBS and assayed
for b-gal activity by incubating at 378C overnight as described30
using solutions from the in situ b-Gal Staining kit (Stratagene,
Santa Clara, CA, USA). Some of the globes were bisected at the
equator before the staining. Isolated lens were also immersed
in staining solution after carefully ripping apart the lens
capsule and directly exposing the inside of the lens to the X-gal
solution. After staining, tissues were washed again with PBS,
post-fixed in cold 4% PFA for 30 minutes, washed with PBS/3%
dimethyl sulfoxide, followed by PBS, rinse in distilled water,
and transferred to 70% ethanol for delivery to the UNC
histology core for paraffin embedding. Some of the stained
whole eyes were post-fixed with 4% PFA, 2.5% glutaraldehyde
overnight at 48C, and embedded in Technovit GMA resin with
Technovit GMA 7100 Hardener II (Heraeus Kulzer, GmbH,
Bensheim, Germany) following described procedure.31,32
Histology
Paraffin blocks were sectioned at 5 lm by meridional
orientation, sections mounted on glass slides (Superfrost Plus;
Thermo Fisher Scientific, Waltham, MA, USA) and counter-
stained with hematoxylin and eosin. Technovit plastic blocks
were equally sectioned at 3 to 5 lm on a Microm HM 355S
Microtome (Thermo Fisher Scientific). Sections were dried for
5 minutes on a 558C hot plate (C&A Scientific, Manassas, VA,
USA), stained with toluidine blue and cover-slipped with
Permount mounting medium (Thermo Fisher Scientific).
Images were taken on a model IX71 Olympus microscope
(Olympus, Center Valley, PA, USA) equipped with a digital
DP70 camera (Olympus) and software package (Olympus).
Digital images were arranged with image analysis software
(Photoshop CS; Adobe Systems, Inc., San Jose, CA, USA).
RESULTS
Generation of an Mgp-Cre Knock-In Mouse Line
Molecular expression analyses have revealed that the MGP is
one of the most abundant genes in the human TM,12,15,33,34 a
level of expression that also translates into the mouse (our own
unpublished data). However the localization and distribution of
the MGP expression in the eye, and therefore the elucidation of
its relevance in eye disease is unknown. This prompted us to
use mouse genetics technology to generate an Mgp-Cre knock-in
line that upon crosses with Cre-mediated reporter strains would
allow to accurately determine the spatial and temporal
expression of Mgp in the eye tissues. To do this we designed
a targeting vector where an expression cassette containing an
IRES-Cre-FRT-flanked Neo cDNA cassette was inserted in
between 50 and 30 arms of the Mgp gene, rendering the Cre
under the transcriptional control of the Mgp gene (Methods and
Fig. 1A). The linearized vector was electroporated into Prx-
B6N#1(C57BL6/N) ES cells and G418 resistant clones were
screened for the gene targeting event. Correct targeting G418
resistant, positive-selected ES clones were confirmed by
Southern Blot. Nine correctly targeted ES clones were injected
into B6 albino recipient blastocysts to produce chimeras. Five
chimeras were bred with B6 albino mice, and of these, two
showed germline transmission of the MgpCre-Neo knock-in allele
(Mgp-Cre-Neo line). The Neo cassette was subsequently excised
from the two founder lines by crossing them with the FLP
deleter mice to produce the line MgpCre-delNeo/þ;FLP/þ (Mgp-
Cre-delNeo-FLP line). The introduced FLP gene was removed by
intercrosses of the MgpCre-delNeo/þ;FLP/þ mice to produce the
MgpCre-delNeo/þ;FLP/ mouse line (hereafter called MgpCre allele
and Mgp-Cre knock-in line). Genotyping by PCR of all
intermediate and final mouse lines (Methods) confirmed the
presence and/or absence of each of the corresponding alleles.
Thus, the Mgp-Cre-Neo knock-in line showed the 890 and 270
bp amplimers (Figs. 1B, 1E); the Mgp-Cre-delNeo-FLP line
showed the 690 and 750 bp amplimers (Figs. 1C, 1E) and the
final Mgp-Cre knock-in line showed the absence of the 890 and
750 bp amplimers and the presence of the 690 bp amplimers
(Figs. 1B–E).
C57BL6/N mice have been recently shown to harbor the
rd8 mutation in the Crb1 gene, which in the homozygous state
causes retina degeneration.29 Because the ES cells used here to
generate chimeras were from a 6/N mouse, the Mgp-Cre knock-
in line was crossed with C57BL/6J WT mice to select for the
absence of the rd8 mutation (MgpCre; Crb1þ/þ). Male and
female cohorts exhibiting the 220 bp WT allele and lacking the
241 bp amplimer representative of the rd8 mutation were
selected and bred for the maintenance of the Mgp-Cre knock-in
line.
While Mgp KO mice die 5 to 6 weeks after birth,
heterozygous MgpCre/þ and homozygous, MgpCre/Cre mice were
viable, fertile, normal in size and phenotypically identical to
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their wild-type littermates, indicating that the transgenic
knock-in was producing the correct Mgp protein.
Functional Recombination of the Mgp-Cre Knock-
In Mouse Line in the Mouse Eye
To determine the spatial and temporal pattern of expression of
the Mgp gene (Cre activity) in the mouse, rd8 mutation-free
mice (heterozygous and homozygous) knock-in progenies
(MgpCre/þ and MgpCre/Cre) were crossed with the Cre-mediated
reporter mouse line R26R-lacZ.35 This reporter mouse
contains a STOP signal for the reporter gene b-gal flanked by
loxP sites. The Cre recombinase, expressed under the Mgp
control, recombines the two loxP sites to remove the STOP
signal of the R26R allele, which results in expression of b-gal.
This Cre-mediated recombination event is irreversible, there-
fore b-gal reporter expression can be identified in all cells
expressing the Mpg gene. The mouse progeny obtained by
crossing the Mgp-Cre line with the R26R-lacZ reporter was
termed Progeny P (double heterozygous MgpCre/þ; R26RlacZ/þ;
hereafter called Mgp-lacZ knock-in; Fig. 2, top). For this mouse,
genotyping results showed the corrected amplimer’s size for
the four alleles: 579 (WT), 690 (Cre-delNeo Knock-in), 650
(R26R nonrecombined allele), and 340 bp (R26R recombined
allele; Fig. 2, bottom left). Control mice, Mgpþ/þ; R26RlacZ/þ
lacked the Mgp-Cre knock-in allele and were termed progeny Q
(Fig. 2, bottom left). Confirmation of the rd8 mutation-free
status for progeny P was obtained by genotyping its DNA with
primer pairs #8 and #9 (Methods), using positive and negative
controls (Fig. 2, bottom right).
All mice from Progeny P showed functional recombination
in the eye. In total, we examined and confirmed Cre-mediated
expression in 43 experimental and eight control mice, ages 1
to 8 months from different breeding pairs and from two
founders. The blue b-gal staining indicative of high levels of Cre
activity was intense and consistently present in just two areas
of the eye globe. The first area comprised the TM region,
extending to the ciliary muscle and the suprascleral zone above
the Schlemm’s canal. The second area included the sclera
tissue that surrounds the eye, in particular at the ppSC region
surrounding the ON. The staining was equally observed when
tissues were stained as whole globes (Fig. 3A, left) or after
bisecting them (Fig. 3A, right). Both these areas, TM and ppSC
region are well-established glaucomatous-relevant tissues. No
expression was observed in the cells of the retina, iris, ciliary
body, cornea, or lens (Fig. 3B). Blood vessels piercing through
the retina were stained blue (VSMCs; see below, Fig. 6).
Staining of lens cells was also negative after opening the
capsule previous to X-gal treatment, in two double heterozy-
gous positively blue mice (n ¼ 4 lens; not shown).
Expression of Mgp-Cre in the Anterior Segment Is
Restricted to Trabecular Meshwork and Immediate
Surrounding Tissues
High resolution plastic- and paraffin-embedded sections from
the anterior segment showed that the expression of Cre-
mediated Mgp was specifically targeted to the entire outflow
region including cells from the inner and outer walls of the
Schlemm’s canal, inner and outer walls, and scleral cells
located above the outflow drainage area (Fig. 4). The Cre-
mediated expression was remarkably intense in all layers of the
TM. Cells from uveal, trabecular, and juxtacanalicular layers
appeared deeply blue, indicating a high transcription level of
the Mgp gene. The expression was sharply stopped just below
the inferior region of the TM marking a clear expression/no-
expression line in between the outflow tissue and the ciliary
body. Likewise, expression was also clearly stopped at the
anterior TM region and no cells of the cornea endothelium
showed Cre-mediated activity. The ciliary muscle, which
intertwines with the posterior region of the TM was also
heavily stained. The location of expression was well conserved
in all mice of the Mgp-lacZ line. Figure 4 shows a
representative set of mice, all 4- to 6-weeks old, which
originated from different breeding pairs, different combina-
tions of homozygous and heterozygous Mgp-Cre knock-in, and
from mice from a second founder, all mated with R26R-lacZ
mice. Mice 1 to 4 were heterozygous progeny P (MgpCre/þ;
R26R lacZ/þ), while mouse 5 was a progeny Q control (Mgpþ/þ;
R26RlacZ/þ). The localization of the Mgp Cre–mediated
expression was nearly identical in all offspring. These
histologic localization results allowed us to finely tune and
define the original observation that the mRNA abundance of
the MGP/Mgp’s gene in the human and mouse from dissected
TM tissue was among the highest expressed genes,12,13,33,34
and unpublished.
Expression of Mgp-Cre in the Posterior Segment Is
Highly Efficient at the Peripapillary Scleral Region
In the posterior segment, expression was restricted to the
sclera. None of the cells of the retina, retinal pigment
epithelium (RPE), photoreceptors, glia, or RGCs show Mgp-
Cre–mediated expression. In the sclera, staining was not
observed at the periphery and started to be seen at the
midanterior and posterior regions. The Mgp-Cre–mediated
expression increased posteriorly and was mainly restricted to
the sclera cell layer localized immediately underneath the
choroid, while most of the outer scleral cells were not stained
(Fig. 5). This particular scleral cell layer has been described as
to be formed by chondrocytes in several animal species.36,37
Chondrocytes in other tissues, such as cartilage, exhibit high
expression levels of the Mpg gene, which is responsible for
maintaining their tissue softness. As it approached the ON
region the whole width of the sclera was heavily stained, and
the ppSC region surrounding the ON was completely blue (Fig.
6). As above, we examined eyes from different breeding pairs,
from Mgp-Cre homozygous and heterozygous crosses with the
R26R-lacZ mouse and from two founders. Figure 6 shows a
representative set of seven eyes cross-sectioned through the
ON and all of them exhibiting the same general expression
pattern. All mice except mouse 5 were progeny P double
heterozygous eyes. Mouse 5 was a progeny Q control which
does not carry the Cre allele. We also observed Mgp-driven Cre
expression in occasional sectioned vessels piercing through
the retinal ganglion cell layer as well as in the retinal central
artery. This observation fits well with the established known
expression of this gene in the arteries, whose calcification
leads to the death of the Mgp-KO mouse at 5 to 6 weeks of age.
Together, these results indicate that the Mgp gene is an
important component of the scleral region supporting the ON
and that, given its natural function of inhibiting calcification,
could have a key role in regulating the stiffness at the ppSC
region.
Mgp-Cre Activity Continues to Be Strong at 6 Months
and Appears to Diminish at 8 Months
The Mgp-driven Cre expression, evaluated by the b-gal
reaction, was observed at the same sites in mice of 2.5, 4,
and 6 months while it appears to be diminished at 8 months
(Fig. 7). This result indicates that the expression of the Mgp
gene in the TM and supporting sclera is constantly required
during adulthood. Confirmation of the localization of expres-
sion restricted to the TM and scleral supporting the ON was
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obtained by the same in situ enzymatic assay for b-gal in mice
obtained from crossing the second founder with the R26R-lacZ
mouse (Fig. 7).
DISCUSSION
In living animals, the efficiency of a Cre-mediated recombina-
tion is very high, with only four Cre molecules required for one
recombination event.38 Thus, detection of gene expression
using the Cre-mediated expression approach is well above
conventional methods and makes this technology an ideal tool
to study specific and, most important, localized gene expres-
sion in living animals. In this study, an IRES-Cre gene was
knocked-in into the Mgp gene of a living mouse after its
translational STOP signal (Mgp-Cre knock-in line). In this
engineered mouse, expression of Cre is under the control of
the entire Mgp regulatory regions, and thus its expression
represents a true Mgp-tissue specific expression. Crossing the
knock-in mouse with the R26R-lacZ reporter, we demonstrat-
ed that the Mgp anticalcification/antistiffness gene in the eye is
highly expressed in the glaucoma-associated tissues TM, ciliary
muscle, and ppSC. This pattern of expression was consistent
among mice from different breeding pairs and from different
germline founders indicating a real Mgp localization in the
mouse eye. Also, in the recombinant mouse, Mgp expression in
noneye cartilaginous tissues agreed well with the known
distribution pattern of the gene (unpublished results), sup-
porting the same function of the gene in the eye.
In the TM, high levels of MGP expression and MGP IOP
response have been shown by us and others to occur in
dissected TM tissue/TM primary cells of humans and pigs using
biochemical and molecular methods.12,13,15,33,34,39,40 By the
same methods, our laboratory showed that such high presence
in the TM was extended to the mouse eye (unpublished).
However, histologic localization of gene expression is key for
understanding a gene’s role in disease and no MGP localization
data was available for the eye of any species. Here, we show
that Mgp expression is not strictly limited to the TM cells, but
that it extends, albeit in a confined manner, to the immediately
surrounding areas such as the ciliary muscle and sclera region
above the Schlemm’s canal. Given the anticalcification/antistiff-
ness functions of the MPG gene in all other body systems, our
results suggest that the presence of this gene in the outflow
pathway and outflow surrounding regions is needed to
maintain the appropriate softness and elasticity required to
FIGURE 2. Generation of the recombinant Mgp-lacZ knock-in mouse. Top, an schematic representation of the cross between the Mgp-Cre Knock-in
mouse and the Cre-mediated reporter R26R-lacZ to generate the Mgp-lacZ mouse. Bottom, genotyping of the genomic DNA from the Mgp-lacZ and
control mice: left; primer pairs 1, 4 (Fig. 1) 6, and 7 (Jackson laboratories); right, primer pairs 8 and 9 to identify the rd8 mutation (primer
sequences in methods).29 All amplimers match the expected sizes. Mgp-lacZ mouse does not harbor the rd8 mutation in the Crb1 gene. lacZ, b-
galactosidase.
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facilitate aqueous humor flow. Thus, the expression of Mgp not
only in the TM, but on the ciliary muscle and immediate sclera
above the canal emphasizes the importance of this gene in
coordinating tissues involved in the regulation of IOP.
The second main site of Mgp gene expression in the eye
was the sclera, in particular, the ppSC. Blue cells started
appearing on the midsclera and were restricted to the layer
immediately underneath the choroid. The expression contin-
ued to increase toward the posterior sclera and had the highest
intensity and expansion at the ppSC supporting the ON. This
result would indicate that the ppSC region is in need of a
stronger protection from stiffness/calcification, and that would
be mediated by the increased expression of Mgp. Because MGP
is recognized as a key cartilage gene,17,20,41 our findings fit
with, and also elucidate earlier sclera reports on the nature of
scleral cells. It has been known that the inner portion of the
sclera of many vertebrate species contains a cartilaginous layer
in addition to the fibrous layer found in mammals.42 This
scleral characteristic has been well-studied in myopia models in
birds37,43 where chondrocytes were identified in the sclera of
myopic eyes. Further, similar to what we observed on the
mouse sclera with Mgp, it has been noted that the presence of
chondrocytes displays regional differences, and is increased in
the posterior sclera.43 Primary chondrocytes have also been
isolated and characterized from the chick embryo sclera.44
In mammals, the presence of a cartilaginous sclera has been
reported in rodents,45,46 and more recently in sheep, where it
locates posterior to the tapetal fundus.36 Interestingly, a
microarray hierarchical clustering analyses performed on
cultured scleral cells from postmortem human donors showed
a similar gene profile between the human sclera and cartilage
tissues.47 In Fisher rats, the scleral cartilage is further
converted to bone, and 95% of the rats showed a calcified
sclera, a condition that increased with age and stress, and
appeared to be sex dependent.46 It is worth noting that sclera
calcification in humans had been reported as early as 1958 by
David Cogan48 and that it has since been described several
times during normal aging, and associated with disease
conditions.49,50 Our findings, revealing the sclera expression
pattern of the anticalcification Mgp gene, provide a first
explanation of the likely mechanism responsible for the long
observed eye sclera calcification.
The degree of stiffness of the sclera has great relevance in
glaucoma. The sclera is the principal load-bearing structure of
the eye and its biomechanical response to elevated IOP
controls the extent of force applied on the optic nerve head
(ONH)51,52 Deformation of the ONH due to the IOP-stresses is
FIGURE 3. Functional recombination in Mgp-lacZ knock-in mouse line. Five-lm meridional sections from X-gal–stained MgpCre/þ; R26RlacZ/þ eyes
from 4- to 6-weeks old, and counterstained with hematoxylin and eosin. Sections were from three different breeding pairs of one founder. (A)
Stained whole globes embedded in Technovit plastic resin (two left images) and stained bisected eyes embedded in paraffin (right image). The
expression of lacZ is readily detectable in only two regions of the eye: the anterior segment TM and the posterior segment ppSC. lacZ expression is
also observed in the inner layer of the midsclera. (B) Detailed meridional sections of the cornea, lens, retina, and ciliary body from the same mouse.
No lacZ staining was observed in these tissues. Occasional blue staining is seen in capillaries crossing the RGC cell layer. There is a clear
demarcation between the ciliary body (not stained) and the TM, heavily stained. Expression of lacZ is limited to two glaucoma-relevant tissues.
Original magnifications: (A) 340 (B) 3200. INL, inner nuclear layer; ONL, outer nuclear layer; CM, ciliary muscle.
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a clinical landmark of glaucoma and affects the axons and
survival of the RGC cells. In the ppSC, scleral collagen and
elastic fibers are circumferentially oriented around the ONH
and provide a mechanical support in this region.10 Measure-
ments of modulus of elasticity and tensile strength have
determined that the elasticity of the sclera diminishes with age,
thus increasing its stiffness.53,54 In the mouse, the structure of
the sclera changes with pressure elevation showing alteration
in fibrillar content and orientation, which would be consistent
with increased stiffness.8,55 The presence of an anticalcifica-
tion/antistiffness protein in the same specific scleral area
where stiffness has proved to be an issue is intriguing, and a
strong indication of the role of Mpg in protecting such region
from elevated IOP and glaucoma. It would be logical to assume
that a less stiff, more flexible sclera would be able to shock-
absorb better IOP fluctuation forces and protect the ON.
Even using this sensitive expression technology, Mgp
expression is not observed in the cornea, lens, iris, ciliary
epithelium, or in any of cells of the layers of the retina. Although
it has been described that the lens undergoes a calcification
FIGURE 4. Mgp Cre–mediated lacZ anterior segment expression. Five-lm meridional sections from X-gal–stained eyes from 4- to 6-week-old mice
counterstained with hematoxylin and eosin. Mice 1 through 4 were from different breeding pairs. Mice 4 and 5 originated from a second founder.
Mouse 4 is the Mgp-lacZ double heterozygous (MgpCre/þ;R26RlacZ/þ) and mouse 5 is the littermate no Cre allele control (Mgpþ/þ;R26RlacZ/þ). Eyes
from mice 1 and 2 were stained as whole globes and embedded in Technovit plastic resin. Mice 3, 4, 5 were stained as bisected specimens and
embedded in paraffin. All crosses resulted in a similar expression pattern. lacZ expression was confined to the TM region. Al layers of the TM were
heavily stained with X-gal, including the Schlemm’s canal inner and outer wall. High lacZ expression was also observed in the ciliary muscle and on
the sclera cells above the outflow region. Original magnifications: left column: 3100, middle column: 3200, right column: 3400.
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process with age and during cataract formation,56 no expression
of Mgp was observed in the lens cells. This would agree with the
authors’ interpretation that calcification in the lens had no
cellular participation.56 Overall, the lack of MGP expression in
other than the glaucoma-associated tissues also indicate that the
property of stiffness is not as important for them as it could be
for the TM, ciliary muscle, and ppSC.
Although the majority of this first set of studies was
targeted to the 1-month-old mouse, we examined mice up to 8
months of age. The fact that Mgp expression continues to be
very strong at 6 months indicates the continuous need of
preserving the softness of those glaucomatous-relevant
tissues during adulthood. Although at this time quantification
measurements are not available, there appears to be a decline
FIGURE 5. Mgp Cre–mediated lacZ expression in the sclera. Five-lm meridional section from representative MgpCre/þ; R26RlacZ/þ 4.5-week-old
mouse stained as a whole globe with X-gal, embedded in paraffin and counterstained with hematoxylin and eosin. Expression of lacZ is not
observed at the anterior sclera. It is beginning to show at the mid sclera and is highly expressed at the ppSC region. In the mid sclera, expression is
mostly seen in the cell layer immediately underneath the choroid (chondrocyte layer).
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FIGURE 6. Mgp Cre–mediated lacZ expression in the ONH region. Five-lm meridional sections from X-gal–stained eyes from 4- to 6-week-old and
counterstained with hematoxylin and eosin. Mice 1, 3, and 4 are posterior segments of specimens shown in Figure 4. Mice 6 to 9 were from
different breeding pairs. Mice 7 and 8 and 4 and 5 were littermates. Mouse 5 is the no Cre allele control (Mgpþ/þ; R26RlacZ/þ). Eyes from mice 1, 6, 7,
and 8 were stained as whole globes, with 1 and 6 embedded in Technovit plastic resin and 7 and 8 in paraffin. Mice 9 and 5 were stained as bisected
specimens and embedded in paraffin. X-gal staining is very intense all across the sclera at the ppSC region indicating high expression of Mgp cre–
mediated lacZ. Arrowheads: vascular smooth muscle cells from RGC vessels (mice 3 and 9) and retinal central artery (mice 1, 4, and 8) express
abundant Mgp. All crosses resulted in a similar expression pattern. Original magnification: 3100.
FIGURE 7. Mgp Cre–mediated lacZ expression with age. Five-lm meridional sections from representative X-gal–stained eyes from 2.5- to 8-months
old and counterstained with hematoxylin and eosin. Top row: TM region; bottom row: ONH region. The 2.5-month-old mouse images (TM and
ONH) were from littermates, stained as bisected tissues and embedded in paraffin. The TMs and ONHs images of the 4- and 6-month-old mice were
each from the same eye. The 4- and 6-month-old mice were from different breeding pairs, stained as whole globes, and embedded in Technovit
resin. The 8-month-old mouse images are also from the same eye, stained as bisected tissues and embedded in paraffin. The 2.5- and 6 month-old
mice are from the same litter. Expression of lacZ is very high up to 6 months of age and begins to diminish at 8 months, last time point tried.
Original magnifications: Top row: 3400; bottom row: 3200.
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in the expression observed at 8 months. If ratified, this
decline would parallel the increased scleral stiffness found to
occur with age in all species studied.8,10,53,53,55
Finally, there is always the possibility that MGP could have a
totally novel function in the eye, and that the specific expression
we are seeing would be responsible for a different outcome.
However, given the extensive number of studies in the vascular
and cancer field with this gene/protein, such speculation would
seem unlikely. Even if that were to be the case, because the
observed Mgp expression in the eye is restricted to glaucoma-
associated tissues, it would be logical to assume that such new
hypothetical function would also be involved in preventing the
development of the disease. The fact that in the eye, MGP is
expressed in tissues where calcification/stiffness could signifi-
cantly alter their primary function is another indication that
MGP uses its known function in the eye.
Experiments to investigate the function of the gene in
knock-out mice are ongoing. The phenotype of this mouse
though makes the study very limited.17 The reduced size of the
animals, compromised breathing and premature death pre-
cludes an accurate analysis. The generation of an Mgp floxed
mouse to circumvent early death is in progress.
In summary, using mouse genetics we have generated an
Mgp-Cre knock-in mouse where the Cre recombinase is under
the control of most, if not all regulatory sequences of the Mgp
gene. Crosses of this mouse with a lacZ reporter strain have
allowed for the first time to elucidate the location of
expression of this gene in the mouse eye. In addition to its
known presence in the TM, our study revealed specific Mgp
expression in the sclera, which becomes particularly strong in
the ppSC region. To our knowledge, Mgp is the first gene
exclusively expressed in anterior and posterior tissues relevant
for the development of glaucoma, strongly supporting the
presence of a joint calcification/stiffness mechanism and
offering the possibility of single targeting. As a key cartilage
gene, Mgp would contribute to both, maintain the softness of
the outflow region, and prevent the stiffness of the ONH area.
The availability of this Mgp-Cre knock-in mouse is extremely
valuable to investigate the response to glaucomatous insults in
both regions of the eye in vivo. Future crosses of Mgp-Cre
knock-in with fluorescent reporter mice will further allow
performing such studies up longitudinally, in the same animal.
Because Mgp’s only known function (in the vascular, kidney,
and cancer fields) is that of an anticalcification/antistiffness
gene, our findings support that Mgp is a strong candidate for
regulation of stiffness in glaucoma-associated tissues.
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